THE BUZ ON CANNABIS STOCK




Cannabis Stock 

CANNABIS BUZZ Pure play marijuana stocks are scarce. Most companies in the marijuana industry trade over the counter (OTC), where solid information regarding operations and financials is difficult to retrieve. Exceptions extend to issues such as GW Pharmaceuticals plc (NASDAQ: GWPH), a British biopharmaceutical company that developed two cannabis-based drugs licensed for use outside the United States. Sativex is used to treat muscular contractions in multiple sclerosis patients, and Epidiolex targets epileptic seizures in children. Both drugs have entered Phase 3 clinical stage trials in the United States. GWPH has a $2 billion market cap and had returned 23% year to date (YTD) as of Aug. 15, 2016.

Political and legal obstacles remain the highest hurdles for the marijuana industry in 2016. Four states, Oregon, Washington, Alaska and Colorado, have legalized recreational marijuana, and 25 states plus the District of Columbia have approved cannabis for medicinal purposes. The plant is categorized at the federal level as a Schedule 1 drug, possessing the highest risk for psychological and physical dependence, and more curiously, having no acceptable medical use.

InMed Continues to Make Significant Strides on Biosynthesis Program Development     Significant Strides inMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today an update to its investors and stakeholders on the significant advancements in its proprietary
Complete Reading

InMed Pharma: A Leader in Cannabinoid Biosynthesis — CFN Media InMed Pharmaceuticals CFN Media Group (“CannabisFN”), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering how InMed Pharmaceuticals Inc. ( CSE :IN ) ( CNSX : IN ) (IN.CN) ( OTCQB : IMLFF ) is leveraging biosynthesis to solve a major problem in the medical cannabis
Complete Reading

Two Rivers Executes Amended Water Supply Agreement Doubling Potential Supply for Development Two Rivers Water & Farming Company (“Two Rivers”) ( OTCQB : TURV ) and its subsidiaries, including Water Redevelopment Company (“Water Redev”) announced today it has executed a second amendment to its water supply agreement with a real estate developer, Marksheffel-Woodmen Investments, LLC and Family Ranch Holdings,
Complete Reading

Hemp, Inc. Announces Agreement with One Step Vending, Corp. for Development of Hemp Oil-Based Consumer Products Hemp, Inc. ( OTC PINK : HEMP ) is pleased to announce that it has signed an agreement, formalizing a venture with One Step Vending, Corp. ( OTC PINK : KOSK ), a holding company focused on the acquisition of market-changing and disruptive business models, with an emphasis on
Complete Reading

American Cannabis Company, Inc. Signs Exclusive Distribution Agreement with Earth Alive American Cannabis Company, Inc. (OTCQB : AMMJ ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has signed an exclusive distribution agreement with Earth Alive, a leading Canadian clean-tech company that develops and manufactures state-of-the-art microbial
Complete Reading

Create Account



Log In Your Account



Dash_En